Pilot Study Based on Technology Solutions for Hypertension Care
Pilot Study of Information and Communication Technology Solutions for Hypertension Care
1 other identifier
interventional
65
1 country
1
Brief Summary
The goal of this clinical trial is to understand whether the adoption of digital solutions by healthcare professionals and patients improves the management of patients with high blood pressure. The main questions it aims to answer are:
- are these digital solutions feasible and well accepted by patients?
- can these solutions, compared to standard care, allow a better hypertension control in patients with high blood pressure? Participants randomised to one of the two intervention arms will be asked to adopt the digital solutions that include a smartphone app and 2 devices for blood pressure and body weight measurement that will be connected to the app. Researchers will compare patients randomised in the two intervention groups with patients randomised to standard care (control group)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 17, 2022
CompletedFirst Submitted
Initial submission to the registry
March 20, 2023
CompletedFirst Posted
Study publicly available on registry
April 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFebruary 29, 2024
February 1, 2024
1 year
March 20, 2023
February 28, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in blood pressure
The changes in systolic and diastolic blood pressure
2 and 6 months
Secondary Outcomes (1)
The user satisfaction measured with VAS
2 and 6 months
Other Outcomes (1)
Quality of life measured with EQ-5D
2 and 6 months
Study Arms (3)
Solution 1 - HSmartBPM (developed by a supplier consortium led by GNOMON)
OTHERSolutions consist of devices (e.g., blood pressure monitors, body composition scales) working together in an ecosystem enabled by a user-facing service and associated interfaces. Users are invited to a dedicated training session at the pilot site to officially become enrolled and begin using the solution for an extended period of time. During that time, users are instructed to use the solutions based on recommendations by their treating physicians (e.g., regular measurement of blood pressure using the solution, or scheduling of regular visits via the solution interface). Questionnaires are administered via the solution's interface at the beginning and end of the trial duration. At the end of the trial, the user is asked to return the devices to the pilot site.
Solution 2 - HyperHealth (developed by a supplier consortium led by TECH4CARE)
OTHERSolutions consist of devices (e.g., blood pressure monitors, body composition scales) working together in an ecosystem enabled by a user-facing service and associated interfaces. Users are invited to a dedicated training session at the pilot site to officially become enrolled and begin using the solution for an extended period of time. During that time, users are instructed to use the solutions based on recommendations by their treating physicians (e.g., regular measurement of blood pressure using the solution, or scheduling of regular visits via the solution interface). Questionnaires are administered via the solution's interface at the beginning and end of the trial duration. At the end of the trial, the user is asked to return the devices to the pilot site.
control
OTHERthe control group where they will be followed according to standard care
Interventions
randomised controlled trial where patients with hypertension will be randomised either to one of the two digital solutions
randomised controlled trial where patients with hypertension will be randomised r to standard care
Eligibility Criteria
You may qualify if:
- Diagnosed with essential hypertension (\>140/90 mmHg or normal BP with antihypertensive treatment)
- Basic ICT knowledge and ability to access the internet at home and on mobile devices
- aged 18+
- ability to provide written informed consent, giving informed consent.
- written informed consent
You may not qualify if:
- inability to consent
- chronic renal replacement therapy (haemodialysis, peritoneal dialysis or transplantation) or if, at baseline, there is a history of active malignancy within the last five years
- pregnancy
- illiterate
- younger than 18 years
- being a prisoner
- being institutionalized
- the patient is mentally or psychiatrically ill
- the patient has barriers to understand the implications of participation to the study
- the patient is critically ill or dying
- the patient is extremely poor
- the patient has a learning disability
- the patient is sedated or unconscious
- the patient is a refugee with no permanent permission to stay
- the patient does not have a good command of the language
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Istituto Auxologico Italiano IRCCS
Milan, 20149, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gianfranco Parati, MD
Istituto Auxologico Italiano
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2023
First Posted
April 19, 2023
Study Start
December 17, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
February 29, 2024
Record last verified: 2024-02